Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-316

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 67457-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Decitabine Chemical Structure (Decitabine Chemical Structure)

Chemical structure of decitabine, depicting a nucleoside analog with a pyrimidine base and a sugar moiety, consistent with the active ingredient decitabine in the injection powder product.*

FDA Label Image

Decitabine Carton Image (Decitabine Carton Image)

Label for Decitabine injection, 50 mg per vial, a lyophilized powder for intravenous infusion. Packaging includes dosage strength and usage instructions, labeled as a cytotoxic agent. Manufactured for Mylan Institutional LLC, Morgantown, WV. Storage and reconstitution details are provided alongside a barcode and product NDC 67457-316.*

FDA Label Image

Decitabine Vial Image (Decitabine Vial Image)

Decitabine for Injection 50 mg/vial carton label for intravenous injection, lyophilized powder. The label states the product is a single-dose vial, cytotoxic agent warning, and provides storage conditions. Labeler is Mylan Institutional LLC, manufactured by Pharmascience Inc. Bar code and NDC 67457-316 are visible.*

FDA Label Image

Manufacturer Statement (Manufacturer Statement)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.